34975308|t|Early Toll-like receptor 4 inhibition improves immune dysfunction in the hippocampus after hypoxic-ischemic brain damage.
34975308|a|Background: Toll-like receptor 4 (TLR4) is implicated in neonatal hypoxic-ischemic brain damage (HIBD), but the underlying mechanism is unclear. Hypothesis: We hypothesized that TLR4 mediates brain damage after hypoxic ischemia (HI) by inducing abnormal neuroimmune responses, including activation of immune cells and expression disorder of immune factors, while early inhibition of TLR4 can alleviate the neuroimmune dysfunction. Method: Postnatal day 7 rats were randomized into control, HI, and HI+TAK-242 (TAK-242) groups. The HIBD model was developed using the Rice-Vannucci method (the left side was the ipsilateral side of HI). TAK-242 (0.5 mg/kg) was given to rat pups in the TAK-242 group at 30 min before modeling. Immunofluorescence, immunohistochemistry, and western blotting were used to determine the TLR4 expression; the number of Iba-1+, GFAP+, CD161+, MPO+, and CD3+ cells; ICAM-1 and C3a expression; and interleukin (IL)-1beta, tumor necrosis factor (TNF)-alpha, and IL-10 expression in the hippocampal CA1 region. Result: Significantly increased TLR4 expression was observed in the left hippocampus, and was alleviated by TAK-242. The significant increases in Iba-1+, MPO+, and CD161+ cells at 24 h and 7 days after HI and in GFAP+ and CD3+ T cells at 7 days after HI were also counteracted by TAK-242, but no significant differences were observed among groups at 24 h after HI. ICAM-1 expression increased 24 h after HI, while C3a expression decreased; TAK-242 also alleviated these changes. TNF-alpha and IL-1beta expression increased, while IL-10 expression decreased at 24 h and 7 days after HI; TAK-242 counteracted the increased TNF-alpha and IL-1beta expression at 24 h and the changes in IL-1beta and IL-10 at 7 days, but induced no significant differences in IL-10 expression at 24 h and TNF-alpha expression at 7 days. Conclusion: Early TLR4 inhibition can alleviate hippocampal immune dysfunction after neonatal HIBD.
34975308	6	26	Toll-like receptor 4	Gene	29260
34975308	47	65	immune dysfunction	Disease	MESH:D007154
34975308	91	120	hypoxic-ischemic brain damage	Disease	MESH:D002534
34975308	134	154	Toll-like receptor 4	Gene	29260
34975308	156	160	TLR4	Gene	29260
34975308	188	217	hypoxic-ischemic brain damage	Disease	MESH:D002534
34975308	219	223	HIBD	Disease	MESH:D002534
34975308	300	304	TLR4	Gene	29260
34975308	314	326	brain damage	Disease	MESH:D001925
34975308	333	349	hypoxic ischemia	Disease	MESH:D007511
34975308	351	353	HI	Disease	MESH:D007511
34975308	505	509	TLR4	Gene	29260
34975308	528	551	neuroimmune dysfunction	Disease	MESH:D006331
34975308	577	581	rats	Species	10116
34975308	612	614	HI	Disease	MESH:D007511
34975308	620	622	HI	Disease	MESH:D007511
34975308	623	630	TAK-242	Chemical	MESH:C507035
34975308	632	639	TAK-242	Chemical	MESH:C507035
34975308	653	657	HIBD	Disease	MESH:D002534
34975308	752	754	HI	Disease	MESH:D007511
34975308	757	764	TAK-242	Chemical	MESH:C507035
34975308	790	793	rat	Species	10116
34975308	806	813	TAK-242	Chemical	MESH:C507035
34975308	937	941	TLR4	Gene	29260
34975308	968	973	Iba-1	Gene	29427
34975308	976	980	GFAP	Gene	24387
34975308	991	994	MPO	Gene	303413
34975308	1013	1019	ICAM-1	Gene	25464
34975308	1044	1066	interleukin (IL)-1beta	Gene	24494
34975308	1068	1101	tumor necrosis factor (TNF)-alpha	Gene	24835
34975308	1107	1112	IL-10	Gene	25325
34975308	1187	1191	TLR4	Gene	29260
34975308	1263	1270	TAK-242	Chemical	MESH:C507035
34975308	1301	1306	Iba-1	Gene	29427
34975308	1309	1312	MPO	Gene	303413
34975308	1357	1359	HI	Disease	MESH:D007511
34975308	1367	1371	GFAP	Gene	24387
34975308	1406	1408	HI	Disease	MESH:D007511
34975308	1435	1442	TAK-242	Chemical	MESH:C507035
34975308	1516	1518	HI	Disease	MESH:D007511
34975308	1520	1526	ICAM-1	Gene	25464
34975308	1559	1561	HI	Disease	MESH:D007511
34975308	1595	1602	TAK-242	Chemical	MESH:C507035
34975308	1634	1643	TNF-alpha	Gene	24835
34975308	1648	1656	IL-1beta	Gene	24494
34975308	1685	1690	IL-10	Gene	25325
34975308	1737	1739	HI	Disease	MESH:D007511
34975308	1741	1748	TAK-242	Chemical	MESH:C507035
34975308	1776	1785	TNF-alpha	Gene	24835
34975308	1790	1798	IL-1beta	Gene	24494
34975308	1837	1845	IL-1beta	Gene	24494
34975308	1850	1855	IL-10	Gene	25325
34975308	1909	1914	IL-10	Gene	25325
34975308	1938	1947	TNF-alpha	Gene	24835
34975308	1988	1992	TLR4	Gene	29260
34975308	2030	2048	immune dysfunction	Disease	MESH:D007154
34975308	2064	2068	HIBD	Disease	MESH:D002534
34975308	Association	MESH:C507035	24494
34975308	Association	MESH:D007511	25464
34975308	Negative_Correlation	MESH:C507035	29260
34975308	Positive_Correlation	MESH:C507035	25464
34975308	Negative_Correlation	MESH:C507035	303413
34975308	Negative_Correlation	MESH:C507035	25325
34975308	Negative_Correlation	MESH:C507035	24387
34975308	Association	MESH:D006331	29260
34975308	Positive_Correlation	MESH:D007511	29427
34975308	Negative_Correlation	MESH:C507035	29427
34975308	Negative_Correlation	MESH:C507035	MESH:D007511
34975308	Association	MESH:D007511	29260
34975308	Association	MESH:D002534	29260
34975308	Association	MESH:D001925	29260
34975308	Association	MESH:C507035	24835
34975308	Association	MESH:D007154	29260

